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Abstract 29 
 30 
Tubal ectopic pregnancies are a leading cause of global maternal morbidity and 31 
mortality. Previous infection with Chlamydia trachomatis is a major risk factor 32 
for tubal embryo implantation but the biological mechanism behind this 33 
association is unclear. Successful intra-uterine embryo implantation is 34 
associated with increased expression of endometrial ‘receptivity’ integrins (cell 35 
adhesion molecules). We examined integrin expression in Fallopian tubes of 36 
women with previous C. trachomatis infection, in mice experimentally infected 37 
with C. trachomatis, in immortalised human oviductal epithelial cells (OE-38 
E6/E7) and in an in vitro model of human embryo attachment (trophoblast 39 
spheroid-OE-E6/7 cell co-culture). Previous exposure with C. trachomatis 40 
increased Fallopian tube/oviduct integrin-subunit beta-1 (ITGB1) in women and 41 
mice compared to controls. C. trachomatis increased OE-E6/E7 cell ITGB1 42 
expression and promoted trophoblast attachment to OE-E6/E7 cells which was 43 
negated by anti-ITGB1-antibody. We demonstrate that infection with C. 44 
trachomatis increases tubal ITGB1 expression, predisposing to tubal embryo 45 
attachment and ectopic pregnancy.  46 
Keywords: Ectopic pregnancy, Chlamydia trachomatis, Integrins, embryo 47 
implantation; Fallopian tube 48 
 49 
 50 
  51 
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Introduction  52 
 53 
An ectopic pregnancy is a pregnancy that implants outside the main cavity of 54 
the uterus, most commonly in the Fallopian tube.  It occurs in 1-2% of all 55 
pregnancies worldwide and remains the most common cause of maternal 56 
morbidity and mortality in the first trimester of pregnancy (Jurkovic and 57 
Wilkinson 2011). Chlamydia trachomatis (C. trachomatis) is the most prevalent 58 
curable bacterial sexually transmitted disease worldwide, with estimated 59 
incidence of greater than 100 million cases per year  (WHO 2008). 60 
Epidemiological studies indicate that previous pelvic C. trachomatis infection is 61 
a major risk factor for ectopic pregnancy (Bakken et al. 2007). However, the 62 
mechanism by which C. trachomatis infection leads to tubal implantation is not 63 
understood and does not appear to be a direct consequence of tissue 64 
destruction by the organism (J. L. V. Shaw et al. 2011). We propose that C. 65 
trachomatis infection of tubal epithelial cells may alter their phenotype 66 
predisposing to ectopic embryo attachment and implantation later in a woman’s 67 
reproductive life. 68 
 69 
In the human uterus, the putative 'window of receptivity' to the embryo (that is 70 
required for successful intra-uterine implantation to occur), in the mid-luteal 71 
phase of the menstrual cycle, is accompanied by increased endometrial 72 
expression of integrin heterodimers, composed of the integrin subunits (ITG) 73 
alpha 1 (ITGA1), beta 1 (ITGB1), alpha 4 (ITGA4), alpha v (ITGAV) and beta 3 74 
(ITGB3) (Lessey 1998). Integrins are a family of widely-expressed cell surface 75 
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receptors that mediate cell–cell and cell–extracellular matrix adhesion and, as 76 
a result, regulate many aspects of cell behavior. Twenty-four different integrin 77 
heterodimers are currently recognized in humans, each comprising a pair of 78 
non-covalently associated ITGA and ITGB subunits (Barczyk et al. 2010). In 79 
addition to providing a physical transmembrane link between the extracellular 80 
environment and the cytoskeleton, they are capable of transducing bi-81 
directional signals across the cell membrane (Hynes 2002). Unlike the uterus, 82 
all five of the ITG markers of receptivity (ITGB1, ITGB3, ITGA1, ITGA4 and 83 
ITGAV) are constitutively expressed throughout the menstrual cycle in the 84 
Fallopian tube epithelium (Brown et al. 2012). We therefore hypothesized that 85 
previous infection with C. trachomatis may predispose to tubal implantation by 86 
increasing tubal integrin expression.  87 
 88 
To address our hypothesis, we examined integrin transcript and protein 89 
expression in the Fallopian tube of women with serological evidence of previous 90 
infection with C. trachomatis. We then assessed integrin expression in 91 
response to C. trachomatis infection in the oviducts of mice and in human 92 
immortalized oviductal epithelial cells (OE-E6/E7). Finally, due to the lack of a 93 
good in vivo animal model of tubal ectopic pregnancy (in animals the abdominal 94 
cavity is the most frequent extra-uterine implanation site) (Brown and Horne 95 
2011), we used an in vitro human trophoblast spheroid (embryo surrogate) – 96 
Fallopian tube epithelial cell co-culture model to investigate the effect of C. 97 
trachomatis exposure and functional blockage of integrin on embryo 98 
attachment. 99 
 100 
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Materials and Methods 101 
 102 
Patient samples 103 
Ethical approval for this study was obtained from the Lothian Research Ethics 104 
Committee (LREC 04/S1103/20, 05/S1103/14, 07/S1103/29), with informed, 105 
written consent obtained from all study participants. Serum samples and full 106 
thickness cross-sections of human Fallopian tube ampulla (total n=26) were 107 
collected from women undergoing hysterectomy for benign gynaecological 108 
conditions. This group of women had a regular 21-35 day menstrual cycle, were 109 
non-smokers, not using contraception and had no obvious evidence of FT 110 
pathology on microscopic examination (as assessed by an expert 111 
histopathologist).  Fallopian tubes samples were saved either into RNAlater 112 
(Applied Biosystems, Warrington, UK) for RNA extraction or into neutral-113 
buffered formalin (NBF) for paraffin embedding. Previous C. trachomatis 114 
infection was determined by an indirect enzyme-linked immunosorbent assay 115 
to serum Pgp3 antibody (Wills et al. 2009) with a cut-off value for absorbance 116 
at 450 nm of ≥0.473 giving ≥96% specificity (with an observed decline in 117 
seropositivity occurring following the last episode of chlamydial infection). Of 118 
the 26 women, 8 had serological evidence of previous C. trachomatis infection 119 
and 18 had no serological evidence of previous C. trachomatis infection.   120 
 121 
Animal studies 122 
The animal studies were approved by the Moredun Research Institute Ethics 123 
Committee and were conducted adhering to the institution's guidelines for 124 
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animal husbandry under licence from the UK Home Office. Eight week old 125 
female C57/BL6 mice were infected with C. trachomatis (Figure 2a) following a 126 
modified protocol published by Darville et al (Darville et al. 1997) and described 127 
in more detail in Supplementary Information (Animal Studies).  128 
 129 
Isolation of DNA from vaginal swabs and quantitative real-time PCR 130 
DNA was extracted from vaginal swabs using a DNeasy® Blood and Tissue Kit 131 
(Qiagen, Cat No. 69504) according to the manufacturer’s instructions. Evidence 132 
of infection with C. trachomatis was determined by TaqMan real-time PCR 133 
using the C. trachomatis specific primers and probes (see Supplementary 134 
Table 1) (Darville et al. 1997). DNA extraction and qRT-PCR methods are 135 
described in detail in Supplementary Information (Isolation of DNA from vaginal 136 
swabs and quantitative real-time PCR). 137 
 138 
Quantitative reverse transcription PCR for integrin mRNA expression 139 
TaqMan real-time PCR (qRT-PCR) was performed to quantify mRNA 140 
expression levels of human and mouse integrins using specific primers (see 141 
Supplementary Table 1) following the protocol described in Supplementary 142 
Information (Quantitative reverse transcription PCR for integrin mRNA 143 
expression).  144 
 145 
Immunohistochemistry  146 
Immunohistochemistry for ITGB1 in human Fallopian tube samples and Itgb1 147 
in mouse oviducts was carried out on NBF fixed paraffin wax embedded (FPE) 148 
sections following our previously described protocol (Brown et al. 2012) and 149 
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detailed in Supplementary Information (Immunohistochemistry). The primary 150 
antibodies used to detect ITGB1 (both for human as well as human samples) 151 
were rabbit-anti-ITGB1 (Santa Cruz sc-8978, diluted 1:100) or isotype matched 152 
control (Rabbit IgG Dako X0903, diluted 1:100).  153 
 154 
Histoscore calculation 155 
Sections of immunohistochemical staining for ITGB1 were evaluated using 156 
semiquantitative histoscore analysis following previously described method 157 
which considers both the intensity and the percentage of cells stained in each 158 
of four intensity categories (McCarty et al. 1985). Intensities were classified as 159 
0 (no staining), 1 (weak staining), 2 (strong staining) and 3 (very strong 160 
staining). For each stained section, a histoscore was obtained by application of 161 
the following algorithm: histoscore=∑(i+1) × Pi, where i and Pi represent 162 
intensity and percentage of cells that stain at each intensity, respectively, and 163 
corresponding histoscores were then calculated. 164 
 165 
Quantitative dual-fluorescent western blot 166 
Quantitative dual-fluorescent western blot was performed to quantify the ITGB1 167 
and ITGB3 proteins in human Fallopian tube lysates following our previously 168 
established protocol (Brown et al. 2012) and detailed in Supplememntary 169 
Information (Quantitative dual-fluorescent western blot). Primary antibodies 170 
used to detect ITGB1 were rabbit-anti-ITGB1 (Santa Cruz sc-8978, dilution 0.5 171 
µg/ml) and for ITGB3 were rabbit anti-ITGB3 (Santa Cruz sc-14009, dilution 0.5 172 
µg/ml).    173 
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Oviductal epithelial OE-E6/E7 cell culture and C. trachomatis infection 174 
Immortalised human oviductal epithelial OE-E6/E7 cells (sourced from KF Lee, 175 
Hong Kong) were maintained in DMEM/F12 containing 10% fetal bovine serum 176 
at 37°C, 5% CO2. OE-E6/E7 cells were seeded at 5x105 cells per well of a 12-177 
well dish (BD Biosciences) and cultured for 24 hours. Cells were then washed 178 
with PBS and incubated overnight with serum-free DMEM/F12. The OE-E6/E7 179 
cells (triplicate wells) were exposed to live C. trachomatis (serovar E) at MOI 180 
values of 0.1 and 1.0 in serum-free DMEM/F12. Control cells were cultured in 181 
medium alone. After 24 hours, medium was removed and the cells were treated 182 
with Qiagen RLT buffer and frozen at −80°C before RNA extraction.  183 
 184 
Trophoblastic spheroid-oviduct epithelial-cell co-culture model  185 
A previously established co-culture model using human immortalized Swan71 186 
trophoblast cells (kind gift from V. Abrahams, Yale School of Medicine, CT) 187 
(Gipson et al. 2008) and human immortalized OE-E6/E7 oviductal epithelial 188 
cells, designed to simulate trophoblast attachment, was modified 189 
(Kodithuwakku et al. 2012a, Kodithuwakku et al. 2012b). Human immortalized 190 
were cultured in Dulbecco’s Modified Essential Medium (DMEM, Invitrogen) 191 
supplemented with 10% fetal bovine serum (FBS, Invitrogen), 2mM L-192 
glutamine, penicillin/streptomycin (Invitrogen) and non-essential amino acids 193 
(Sigma). Swan71 cells are derived from first trimester trophoblasts and are well 194 
characterised (Straszewski-Chavez et al. 2009). Both cell lines were tested for 195 
mycoplasma prior to use. Swan71 cells were seeded at 2000 cells per well in a 196 
96 well non-adherent round bottom tissue culture plate to encourage spheroid 197 
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development. During this time, confluent 12-well plates of OE-E6/E7 cells were 198 
washed and maintained in serum-free conditions. For C. trachomatis infection 199 
experiments, OE-E6/E7 cells were exposed to C. trachomatis, as described in 200 
the previous section. Triplicate wells were treated for 1 hour with 0.1 or 0.01 201 
µg/ml mouse anti-ITGB1 (Clone P5D2: R&D Systems) or equivalent 202 
concentration of isotype-matched control IgG1 (Sigma) prior to careful transfer 203 
of sixteen Swan71 spheroids onto the OE-E6/E7 monolayers and a further 6 204 
hour incubation. Non-adherent spheroids were removed by gentle washing with 205 
PBS before the cells were fixed for 10 minutes in NBF, washed and stored in 206 
70% ethanol. Swan71 spheroids adherence was quantified using light 207 
microscopy. Percentage adherence was derived by division of the number of 208 
spheroids attached by total number of spheroids.  209 
 210 
Statistical analysis 211 
Statistical analysis was performed using GraphPad PRISM, version 6.1. To 212 
allow for small sample sizes, non-parametric testing was applied to analysis of 213 
human and animal studies. As endometrial integrins are upregulated at the 214 
window of receptivity, data were interrogated to detect a significant increase in 215 
integrin transcript and protein levels using the one-tailed Mann Whitney test. 216 
For in vitro work, normality of data was tested using Shapiro-Wilk test and 217 
Kruskal-Wallis or one-way ANOVA accordingly applied, with correction for 218 
multiple comparisons by Dunn’s or Dunnett’s tests, respectively. Differences 219 
were considered significant if P<0.05.   220 
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Results 221 
 222 
ITGB1 expression is increased in the Fallopian tube of non-pregnant women 223 
with evidence of previous C. trachomatis infection 224 
We first investigated mRNA expression levels of ITGB1, ITGB3, ITGA1, ITGA4 225 
and ITGAV in Fallopian tube from women with serological evidence of previous 226 
C. trachomatis infection (non-pregnant and non-smokers). We found that 227 
expression of ITGB1 mRNA was higher (P<0.05) in Fallopian tube from women 228 
with evidence of previous C. trachomatis infection (n=8) compared to those 229 
without (n=18) (Figure 1a). ITGB1 protein expression in Fallopian tube from 230 
women with previous C. trachomatis infection (n=7) correlated with ITGB1 231 
mRNA levels (R=0.442, P=0.026), but changes in protein expression alone, 232 
compared to a control group (n=13), did not reach significance (Figure 1b).  233 
Immunohistochemistry demonstrated abundant Fallopian tube epithelium 234 
ITGB1 expression in women with previous C. trachomatis infection and mild 235 
stromal staining (n=8; Figure 1d, 1g). In contrast, in women without previous C. 236 
trachomatis infection (n=18), only sporadic cell staining was observed (Figure 237 
1c, 1f). Semiquantitative histoscore analysis revealed a significant increase 238 
(P<0.0001) in ITGB1 expression in Fallopian tube epithelial cells in women with 239 
previous C. trachomatis infection as compared to women without previous C. 240 
trachomatis infection (Figure 1h). Although ITGB3 mRNA expression was 241 
increased (P<0.05) in women with previous C. trachomatis infection 242 
(Supplementary Figure 1a), ITGB3 protein levels did not show any significant 243 
changes (Supplementary Figure 1b) nor did they correlate with mRNA levels. 244 
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Tubal expression of ITGA1, ITGA4 and ITGAV were not affected by previous 245 
C. trachomatis infection (Supplementary Figure 1c, 1d and 1e).  246 
 247 
Oviductal Itgb1 expression is increased by C. trachomatis in a mouse model of 248 
previous infection 249 
To investigate causality between C. trachomatis infection and increased ITGB1, 250 
we developed an in vivo mouse model of previous C. trachomatis infection 251 
(Figure 2a). Female C57BL/6 mice were infected intra-vaginally with C. 252 
trachomatis and confirmed to have cleared the infection by day 30 post-253 
infection by qRT-PCR detection of C. trachomatis genomic DNA (n=6) (Figure 254 
2b). Mice infected with C. trachomatis displayed increased expression of 255 
oviductal Itgb1 mRNA compared to sham-infected controls (n=6) on day 60 256 
post-infection (P<0.05) (Figure 2c). Immunohistochemistry to Itgb1 revealed 257 
strongly positive epithelial cells in the oviducts isolated from mice exposed to 258 
C. trachomatis (Figure 2e, 2h), with limited staining in the sham-infected mice 259 
(Figure 2d, 2g). Semiquantitative histoscore analysis revealed a significant 260 
increase (P<0.05) in ITGB1 expression in oviductal epithelial cells in mice 261 
exposed to C. trachomatis as compared to controls (Figure 1h).  Exposure to 262 
C. trachomatis did not cause any significant changes in Itgb3 mRNA expression 263 
levels in murine oviducts (Supplementary Figure 2). 264 
 265 
Exposure to C. trachomatis increases ITGB1 mRNA expression in human 266 
immortalised oviductal epithelial cells  267 
ITGB1 mRNA expression in human immortalised oviductal epithelial OE-E6/E7 268 
cells was significantly increased following 24 hours of exposure to 1.0 269 
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multiplicity of infection (MOI) C. trachomatis compared to control (P< 0.05) 270 
(Figure 3a). Exposure to 0.1 MOI C. trachomatis did not have any significant 271 
effect on ITGB1 mRNA expression.  272 
 273 
C. trachomatis exposure increases trophoblast spheroid attachment to 274 
oviductal epithelial cells by upregulating ITGB1 275 
There are no good animal models of tubal ectopic pregnancy, so to simulate 276 
embryo attachment we used an in vitro trophoblastic spheroid (embryo 277 
surrogate) - Fallopian tube epithelial-cell co-culture model. We demonstrated 278 
that 24 hours exposure of oviductal epithelial OE-E6/E7 cells to 1.0 MOI C. 279 
trachomatis significantly increased trophoblast spheroid attachment 280 
(P<0.0001) (Figure 3b). However, treatment of the C. trachomatis exposed OE-281 
E6/E7 cells with 0.1 µg/ml ITGB1 neutralising antibody (dose selected following 282 
optimisation, data not shown) for 1 hour prior to trophoblast spheroid 283 
introduction, significantly reduced the numbers of spheroids that attached to 284 
the OE-E6/E7 monolayer compared with C. trachomatis exposed OE-E6/E7 285 
cells (P<0.0001) and isotype control (IgG) exposed OE-E6/E7 cells (P<0.0001).  286 
 287 
  288 
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Discussion 289 
 290 
It is accepted that C. trachomatis infection in women predisposes to tubal 291 
ectopic pregnancy; a relationship that continues for many years after the 292 
infection has resolved and that cannot be explained by macroscopic tissue 293 
damage as a result of inflammation (Barczyk et al. 2010, J. L. Shaw et al. 2011). 294 
In this study, we provide mechanistic evidence for changes in cell adhesion 295 
molecule expression that may explain this epidemiological association. Using 296 
ex vivo, animal in vivo and in vitro functional models, we demonstrate that 297 
previous exposure to C. trachomatis infection increases oviductal epithelial cell 298 
expression of the adhesion molecule ITGB1, predisposing to ectopic embryo 299 
attachment. 300 
 301 
Fallopian tube from women with serological evidence of previous exposure to 302 
C. trachomatis expressed higher levels of ITGB1 mRNA, with abundant 303 
immunolocalisation of protein to the Fallopian tube epithelium. This 304 
upregulation of mRNA and localisation of protein was replicated in our in vivo 305 
model of previous C. trachomatis infection and in immortalised oviductal 306 
epithelial cells.  Epithelium-specific expression is important in the context of 307 
ectopic pregnancy, as it is to these cells the embryo will initially attach in vivo. 308 
In utero, integrins are upregulated at the luminal surface of the endometrium 309 
during the window of implantation (Lessey et al. 1992) and interact with 310 
corresponding ligands on the blastocyst trophectoderm to enable attachment 311 
(Burrows et al. 1993). Through the use of our in vitro model of Fallopian tube - 312 
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embryo attachment, we have for the first time been able to show the effect of 313 
over-expression of ITGB1 on embryo attachment. This model allows 314 
investigation of causality in ectopic pregnancy which is not possible by 315 
examining human biopsies of tubal implantation sites where molecular changes 316 
may be an artefact of implantation and/or presence of an embryo as opposed 317 
to a predisposition for ectopic implantation. In addition, in the absence of a good 318 
animal model of tubal ectopic pregnancy, we have utilised an alternative in vivo 319 
model, where mice are exposed to C. trachomatis and allowed to clear the 320 
infection, to study the effects of C. trachomatis on the oviduct. The natural 321 
history of untreated (or treated) pelvic chlamydial infection in women cannot be 322 
observed for ethical and logistical reasons, and randomized controlled trials do 323 
not provide this information because the time from the start of the infection is 324 
unknown. We propose that further study using this model could significantly 325 
contribute to improvements in clinical management of this prevalent infection 326 
(Akande et al. 2010, Howie et al. 2011).  327 
 328 
We acknowledge that our results demonstrate that Fallopian tube ITGB1 329 
increases in response to C. trachomatis infection but do not explain how, the 330 
effect endures following elimination of the infection in the face of oviductal 331 
epithelial cell turnover and regeneration. This effect is also seen in ocular 332 
trachoma where scarring progresses in the absence of detectable C. 333 
trachomatis infection, raising uncertainty about the primary drivers of late-stage 334 
trachoma (Burton et al. 2015).  Persistence (where the organism adopts a 335 
dormant state in the epithelial cells) occurs in a minority of C. trachomatis 336 
infections and may contribute to some cases of ectopic pregnancy (Bjartling et 337 
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al. 2007). In addition, Kessler et al have recently demonstrated the existence 338 
of Fallopian tube stem cells, present along the Fallopian tube epithelial surface, 339 
with the ability to differentiate into an organoid containing both ciliated and 340 
secretory epithelial cell types in culture (Kessler et al. 2015). It would be 341 
interesting to discover if bacterial alterations to the genome of these cells by C. 342 
trachomatis, resulting in persistent ITGB1 upregulation, may account for the 343 
long-term increased risk of ectopic pregnancy. 344 
 345 
We also acknowledge that further work is required to elaborate the full 346 
mechanistic pathway of Fallopian tube ITGB1 regulation by C. trachomatis. 347 
However, we propose that the utilization of host cell ITGB1 that we have 348 
observed in oviductal epithelial cells as a result of C. trachomatis infection, may 349 
be due to a shared bacterial virulence mechanism. C. trachomatis is an obligate 350 
intracellular, Gram-negative bacterium. C. trachomatis switches between an 351 
extracellular, metabolically inactive, infectious form, the elementary body (EB), 352 
and an intracellular replicative form, the reticulate body. Stallman and 353 
Hegemann have recently shown that C. trachomatis EBs produce the adhesin 354 
and invasin molecule Ctad1 (Stallmann and Hegemann 2016). This specifically 355 
binds ITGB1 on epithelial cells and induces clustering of ITGB1 at the epithelial 356 
cell membrane to allow EB entry into the host cell. Another Gram-negative 357 
bacterium, Shigella, upregulates expression of ITGB1 in epithelial cells ITGB1, 358 
in this case to stabilize intestinal epithelial cell adhesion to the extracellular 359 
matrix and prevent cellular detachment (Kim et al. 2009).  Shigellae utilize the 360 
type III secretion system (T3SS) to introduce the effector protein OspE into the 361 
cell, and OspE interacts with the host-cells integrin-linked kinase ILK, which in 362 
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turn upregulates ITGB1 (Kim et al. 2009). C. trachomatis also makes use of the 363 
type III secretion system; a ‘membrane-embedded nanomachine’ that delivers 364 
virulence proteins into a host cell via a hollow needle which then hijack host cell 365 
machinery. Chemical inhibition of T3SS dramatically reduces C. trachomatis 366 
virulence (Muschiol et al. 2006).  It is therefore possible that C. trachomatis 367 
shares a similar bacterial virulence mechanism and that small molecule 368 
inhibitors to such bacterial virulence factors might provide an effective 369 
preventative therapy for ectopic pregnancy in women previously infected with 370 
C. trachomatis. 371 
 372 
In summary, we have shown that C. trachomatis upregulates oviductal 373 
epithelial ITGB1 expression which predisposes to ectopic embryo attachment. 374 
This provides an explanation for the epidemiological association between C. 375 
trachomatis and reproductive life-time risk of ectopic pregnancy. The pathways 376 
and mechanisms leading to long-term over-expression of ITGB1 require further 377 
study but may be a consequence of bacterial effector proteins hijacking cellular 378 
pathways to promote virulence leading to more complex disease outcomes.  379 
  380 
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Figure Legends 526 
 527 
Figure 1: The effect of previous C. trachomatis infection on Fallopian tube 528 
ITGB1 expression in women. (a) Box-and-whisker plots of relative levels of 529 
ITGB1 mRNA expression (measured by qRT-PCR) in Fallopian tube biopsies 530 
from non-pregnant, non-smoking women who tested negative (Ct–ve; n=18) or 531 
positive (Ct+ve; n=8) for previous C. trachomatis infection. The boxes represent 532 
mean values ±1 standard deviation and the whiskers denote the full range of 533 
the data. (*P<0.05, one-tailed Mann Whitney test). (b) Box-and-whisker plots of 534 
levels of ITGB1 protein (measured by western blot analysis) from the same 535 
women (where there was sufficient sample). The boxes represent mean values 536 
±1 standard deviation and the whiskers denote the full range of the data. 537 
(P=0.2, one-tailed Mann Whitney test). (c) and (d) Representative images of 538 
immunohistochemical localization of ITGB1 in Fallopian tube tissue from Ct–ve 539 
and Ct+ve women, respectively. Bar = 50µm. (f) and (g) Higher magnification 540 
of c and d respectively.  Bar = 20µm. (e) Negative IgG control. Bar = 50µm. (h) 541 
Box and whicker plots of ITGB1 histoscore in Fallopian tube biopsies from 542 
women with and without previous C. trachomatis infection. The boxes represent 543 
mean values ±1 standard deviation and the whiskers denote the full range of 544 
the data.  (**** P<0.0001, one tailed Mann Whitney test). 545 
 546 
 547 
 548 
 549 
 550 
 551 
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Figure 2: The effect of previous C. trachomatis infection on Itgb1 552 
expression in the murine oviduct. (a) Schematic representation of C. 553 
trachomatis infection in vivo mouse model (b) C. trachomatis genome copy 554 
number (as a marker of infection) in C57/BL6 mice infected with 107 IFU of C. 555 
trachomatis Serovar E (filled circles) or vehicle alone (dashed line, 556 
indistinguishable from x-axis). (C) Box-and-whisker plots of relative levels of 557 
Itgb1 mRNA expression (measured by qRT-PCR) on day 60 post-infection in 558 
oviducts of control (Ct–ve; n=6) and infected (Ct+ve; n=6) mice. The boxes 559 
represent mean values ±1 standard deviation and the whiskers denote the full 560 
range of the data. (*P<0.05, one-tailed Mann Whitney test).  (d) and (e) 561 
Representative images of immunohistochemical localization of Itgb1 in oviducts 562 
of Ct–ve and Ct+ve mice respectively. Bar = 50µm. (g) and (h) Higher 563 
magnification of c and d respectively. Bar = 20µm. (f) Negative IgG control. Bar 564 
=50µm. (i) Box and whicker plots of Itgb1 histoscore in oviducts of C. 565 
trachomatis infected mice as compare to controls. The boxes represent mean 566 
values ±1 standard deviation and the whiskers denote the full range of the data. 567 
(* P<0.05, one tailed Mann Whitney test). 568 
 569 
 570 
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 572 
 573 
 574 
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Figure 3: Effect of C. trachomatis infection on immortalised human 576 
Fallopian tube epithelial OE-E6/E7 cells and an in vitro model of human 577 
embryo attachment. (a) Box and whisker plots of relative levels of ITGB1 578 
mRNA expression (measured by qRT-PCR) in Fallopian tube epithelial OE-579 
E6/E7 cells following exposure to C. trachomatis for 24 hours (MOI = multiplicity 580 
of infection). The boxes represent mean values ±1 standard deviation and the 581 
whiskers denote the full range of the data. Data are the mean of six biological 582 
replicates. (*P<0.05, Kruskal-Wallis test with Dunn's multiple comparisons post-583 
test). (b) Trophoblast spheroid-oviductal epithelial cell attachment following 24 584 
hours exposure to C. trachomatis +/-  1 hour pre-treatment with 0.1µg/ml anti-585 
ITGB1 antibody. The box-and-whisker plots illustrate percentage adherence 586 
(number of spheroids attached/total number of spheroids) of SW-71 trophoblast 587 
spheroids to oviductal epithelial OE-E6/E7 cells. The boxes represent mean 588 
values ±1 standard deviation and the whiskers denote the full range of the data. 589 
Data are the mean of four biological replicates. (**** P<0.0001, one-way Anova 590 
and Dunnett’s multiple comparisons post-test).  591 
 592 
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 600 
Highlights 
 
 Integrin subunit beta 1 is increased in Fallopian tubes of women and mice 
with evidence of past exposure to C. trachomatis. 
 
 C. trachomatis increases integrin subunit beta 1 in oviductal epithelial cells 
and promotes trophoblast attachment.  
 
 Functional blockage of integrin subunit beta 1 abrogates the attachment of 
trophoblast to oviductal epithelial cells. 
 
Research in Context  
 
 
We present exciting data, derived from a combination of ex-vivo, in-vivo and in-vitro 
models, to explain the mechanism behind the epidemiological association of past 
pelvic chlamydial infection and increased risk of tubal ectopic pregnancy. Our data 
demonstrate that past infection with C. trachomatis increases integrin subunit beta 1 
expression in Fallopian tubes in women and in oviducts in mice. We also show that C. 
trachomatis promotes attachment in an embryo-surrogate co-culture tubal attachment 
model and that this effect is negated by functional blockage of the integrin subunit beta 
1.  
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Supplemental Information 1 
 2 
Animal studies 3 
Mice received 2.5 mg of medroxyprogesterone acetate (Depo-Provera) 4 
subcutaneously for 4 days to increase susceptibility to infection. Thereafter, 107 5 
inclusion-forming units (IFU) of C. trachomatis human serovar E suspended in 30ul of 6 
vehicle (SPG: 250 mM sucrose, 10 mM sodium phosphate, 5 mM L-glutamic acid, pH 7 
7.2), were introduced to the vaginal vault (n=6). Control animals (n=6) received vehicle 8 
alone. Mice were sacrificed 60 days from infection. With n=6 per group, we predicted 9 
that we would be able to detect a standardised difference of ≥1.85 with power of 90% 10 
at 5% significance level. Animals were randomly allocated between treatment and 11 
control groups, no animals were excluded from analysis and there was no investigator 12 
blinding. 13 
 14 
Isolation of DNA from vaginal swabs and quantitative real-time PCR 15 
Vaginal swabs were rehydrated by vigorous vortexing in 200µl of PBS prior to the 16 
addition of 200µl AL buffer. The samples were vortexed again before the addition of 17 
20µl proteinase K solution (supplied with kit) and incubation for 10 minutes at 70°C. 18 
200µl of 100% ethanol was added to each of the samples before the mixture was 19 
added directly onto a DNeasy® column. For the remaining stages of the protocol, the 20 
DNA was prepared on the column as described by the manufacturer and finally eluted 21 
in a total volume of 200 µl elution buffer. Quantitative real-time PCR was carried out 22 
using the primers and probe specific for Ch23S (Supplementary table 1 ) (Darville et 23 
al. 1997). The PCR consisted of 12.5 μl 2X TaqMan Universal master mix II 24 
(Invitrogen, Warrington, United Kingdom), 900 nM of each primer, 250 nM fluorescent 25 
probe and 1μl gDNA, made up to a final volume of 25 μl with sterile deionised water. 26 
Amplification and detection were performed using an ABI Prism 7500 sequence 27 
detection system (Invitrogen), following the manufacturer's standard protocols. 28 
Thermal cycling conditions were: 50°C for 2 min, 95°C for 10 min, then 45 cycles of 29 
95°C for 15 sec and 60°C for 1 min. Genome copy numbers were quantified against a 30 
standard curve prepared from C. abortus genomic DNA as previously described 31 
(Livingstone et al. 2009). Each sample, standard and non-template control was 32 
examined in triplicate.  33 
 34 
Quantitative reverse transcription PCR for integrin mRNA expression 35 
RNA was extracted and treated with DNase using a RNeasy fibrous tissue mini kit 36 
(Qiagen). cDNA was synthesised from 200ng of RNA using SuperScript® VILO™ 37 
cDNA Synthesis Kit (Invitrogen). TaqMan real-time PCR (qRT-PCR) was used to 38 
quantify levels of integrin, housekeeping (UBC and GAPDH, predetermined by 39 
geNorm assay, Primerdesign Ltd) and loading control (18s) transcripts. Specific 40 
primers (Supplementary Table 1) were designed using the Universal Probe Library 41 
Assay Design Center (www.roche-applied-science.com) and used in conjunction with 42 
Universal Probe Library (UPL) FAM labelled probes (Roche Applied Science, Burgess 43 
Hill, UK) or purchased as validated primer-probe sets (Perfect-Probe: Primer Design, 44 
UK). Reactions were performed in triplicate, using 18s to control for loading variation 45 
(FAM labelled probe), under standard conditions in an ABI Prism 7900 (Invitrogen). 46 
18s–integrin ΔCt values obtained were normalised against mean values of 18s-UBC 47 
and 18s-GAPDH ΔCt, prior to normalisation against a cDNA positive control (Fallopian 48 
tube from a post-menopausal patient). For mouse samples, integrin gene expression 49 
was normalized to GAPDH expression, using the 2-ΔΔCt method, and then normalised 50 
against pooled Fallopian tube cDNA from the control group. 51 
 52 
Immunohistochemistry  53 
5µm sections of paraffin embedded tissue (Human Falloipan tube and mouse 54 
oviducts) were mounted onto microscope slides, dewaxed and rehydrated, before 55 
antigen retrieval in 10mM Tris 1mM EDTA pH 9 with 5 min of pressure-cooking. Slides 56 
were washed, incubated with 3% hydrogen peroxide for 30 min, then blocked in normal 57 
horse serum diluted 1:12 in TBS-T20 for 30 min. Slides were incubated with primary 58 
antibody overnight at 4°C (anti-ITGB1 Santa Cruz sc-8978, diluted 1:100) or isotype 59 
matched control (Rabbit IgG Dako X0903, diluted 1:100). They were washed in TBS-60 
T20 before incubation with species specific impress kit for 30 min at room temperature 61 
(Vector Laboratories, Peterborough, UK). After washing and incubation with 3, 3’-62 
diaminobenzidine for 5 min, slides were counterstained with hematoxylin, dehydrated 63 
and visualized by light microscopy, using an Olympus Provis microscope equipped 64 
with a Kodak DCS330 camera (Olympus Optical Co., London, UK, and Kodak Ltd., 65 
Herts, UK). 66 
 67 
 Quantitative dual-fluorescent western blot 68 
50mg wet tissue per sample of Fallopian tube was stabilized in RNALater and was 69 
homogenized in  1ml pH 8.0 lysis buffer (50mM Tris-HCl; 150mM NaCl; 1mM EDTA; 70 
1% Triton-X100, 1% Na-deoxycholate; EDTA-free complete mini protease inhibitors 71 
(Roche Diagnostics, Welwyn Garden City, UK); and Halt Phosphatase Inhibitor 72 
Cocktail (Thermo Fisher Scientific, Loughborough, UK)) using a TissueLyser bead mill 73 
(Qiagen). Protein quantification was performed by Bradford Assay, adapted for the 74 
Cobas Fara centrifugal analyzer (Roche Diagnostics), and samples adjusted to 75 
2mg/ml total protein in lysis buffer, before further 1:1 dilution in 2x NuPAGE LDS 76 
sample buffer (Invitrogen) containing 100mM DTT (Sigma). Gel electrophoresis 77 
(1DGE) was performed in 15-well NuPAGE 4-12% Bis-Tris gels (Invitrogen) using 20 78 
µg of total protein/lane alongside SeeBlue® Plus2 pre-stained molecular weight 79 
standards (Invitrogen). A positive control (Fallopian tube from a post-menopausal 80 
patient) was included in every gel to allow intra-blot comparisons to be made. Gels 81 
were equilibrated for 15 minutes in transfer buffer (50 mM Tris, 40 mM Glycine, 0.05% 82 
SDS), before blotting at 20V (limited to 80 mA/gel) onto polyvinylidene fluoride 83 
membrane (Immobilon P: Millipore, Livingston, UK) in the presence of transfer buffer 84 
+ 10% methanol using a Transblot SD (Bio-Rad Laboratories, Hemel Hempstead, UK). 85 
Blots were then blocked for 30 minutes in TBS-T20 (TRIS-buffered saline containing 86 
0.5% Tween20, pH 7.4) + 2% Marvel (Premier Foods, St Albans, UK) and incubated 87 
for 2 hours with combinations of 0.5 µg/ml rabbit anti-ITGB1 (Santa Cruz sc-8978) or 88 
rabbit anti-ITGB3 (Santa Cruz sc-14009) together with 0.5 µg/ml mouse anti-GAPDH 89 
and anti-β actin and/or negative control antibodies (Abcam) diluted in TBS-T20 + 2% 90 
Marvel. Blots were then washed in TBS-T20 (6 x 3 minutes) and incubated for 1 hour 91 
with ImmPRESS anti-rabbit Ig peroxidase Polymer Detection Kit (Vector Laboratories, 92 
Peterborough, UK) (diluted 1/250) and 0.5 µg/ml of goat anti-Mouse DyLight-488 in 93 
TBS-T20 + 2% Marvel. Blots were then washed (6 x 3 minutes) in TBS-T20 and 94 
DyLight-488 and Cy5 labelling imaged using a FLA-5100 (FUJIFILM Europe GmbH, 95 
Düsseldorf, Germany). Protein band intensities were measured using ImageJ software 96 
(Schneider et al. 2012). After normalizing against the mean value of GAPDH and β-97 
actin, values for integrin-specific labelling were expressed relative to the positive 98 
control. After imaging, blots were stained with Imperial Protein Stain (Fisher Scientific 99 
UK, Loughborough, UK) to confirm uniform blotting efficiency.  100 
 101 
  102 
Supplementary Figure Legends 103 
 104 
Supplementary Figure 1: The effect of C. trachomatis infection on Fallopian tube 105 
expression of integrin endometrial receptivity markers in women. Box-and-whisker 106 
plots illustrating relative levels of integrin mRNA expression (measured by qRT-PCR) 107 
and protein levels (measured by western blot analysis) in Fallopian tube biopsies from 108 
non-pregnant, non-smoking women who tested negative (Ct-ve; n=18) or positive 109 
(Ct+ve; n=8) for previous C. trachomatis infection. (a) mRNA expression levels of 110 
ITGB3. (b) protein levels (where sample sufficient) of ITGB3. (c) (d) and (e) mRNA 111 
expression levels of ITGA1, ITGA4 and ITGAV, respectively. The boxes represent 112 
mean values ±1 standard deviation and the whiskers denote the full range of the data. 113 
*P<0.05 (one-tailed Mann Whitney test).  114 
 115 
Supplementary Figure 2: The effect of previous C. trachomatis infection on Itgb3 116 
mRNA levels in the murine oviduct. C57/BL6 mice were infected with 107 IFU of C. 117 
trachomatis Serovar E or vehicle alone, and levels of C. trachomatis genomic DNA 118 
monitored until not detectable (day 30). Oviducts were then collected for integrin 119 
expression analysis. Box-and-whisker plots of show relative Itgb3 mRNA levels on day 120 
60 post-infection in oviducts of control (Ct –ve; n=6) and infected (Ct +ve; n=6) mice. 121 
The boxes represent mean values ±1 standard deviation and the whiskers denote the 122 
full range of the data. (P=0.1526, one-tailed Mann Whitney test). 123 
 124 
 125 
 126 
Supplementary Table 1. qRT-PCR primer and probe sequences 127 
Ch23S forward  5′-CTGAAACCAGTAGCTTATAAGCGGT-3′  128 
Ch23S reverse  5′-ACCTCGCCGTTTAACTTAACTCC-3′  129 
Ch23S probe (FAM) CTCATCATGCAAAAGGCACGCCG-TAMRA  130 
 131 
Human ITGA1 forward 5′-AATTGGCTCTAGTCACCATTGTT-′3 132 
Human ITGA1 reverse 5′-CAAATGAAGCTGCTGACTGGT-′3 133 
Human ITGA1 UPL probe (FAM) 14 134 
Human ITGA4 forward 5′-GGAATATCCAGTTTTTACACAAAGG-′3 135 
Human ITGA4 reverse 5′-AGAGAGCCAGTCCAGTAAGATGA-′3 136 
Human ITGA4 UPL probe (FAM) 57 137 
Human ITGAV forward 5′-GCCGTGGATTTCTTCGTG-′3 138 
Human ITGAV reverse 5′-GAGGACCTGCCCTCCTTC-′3 139 
Human ITGAV UPL probe (FAM) 64 140 
Human ITGΒ1 forward 5′-CGATGCCATCATGCAAGT-′3 141 
Human ITGΒ1 reverse 5′-ACACCAGCAGCCGTGTAAC-′3 142 
Human ITGΒ1 UPL probe (FAM) 65 143 
Human ITGB3 forward 5′-GGGCAGTGTCATGTTGGTAG-′3 144 
Human ITGB3 reverse 5′-CAGCCCCAAAGAGGGATAAT-′3 145 
Human ITGB3 UPL probe (FAM) 13 146 
 147 
Mouse ITGB1 forward 5′- CTGCTTCTAAAATTGAGATCAGGA-′3 148 
Mouse ITGΒ1 reverse 5′- TCCATAAGGTAGTAGAGATCAATAGGG-′3 149 
Mouse ITGΒ1 UPL probe (FAM) 41 150 
Mouse ITGB3 forward 5′- GTGGGAGGGCAGTCCTCTA-′3 151 
Mouse ITGB3 reverse 5′- CAGGATATCAGGACCCTTGG-′3 152 
Mouse ITGB3 UPL probe (FAM) 31 153 
 154 
Human 18S (VIC)                                               Applied Biosystems (4308329)  155 
Human GAPDH (FAM) Primer Design (HK-PP-hu-600) 156 
Human UBC (FAM) Primer Design (HK-PP-hu-600) 157 
 158 
Mouse GAPDH (VIC) Applied Biosystems (4352339E)  159 
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